The effects of the COVID-19 pandemic on patients with lysosomal storage disorders in Israel

The effects of the COVID-19 pandemic on patients with lysosomal storage disorders in Israel

Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is the causative agent of the current COVID-19 pandemic. Lysosomal storage disorders (LSD) comprise of 70 inherited inborn errors of metabolism. Affected individuals suffer from multi-systemic involvement with variable...

Full description

Bibliographic Details
Main Authors: Eyal Kristal, Ben Pode-Shakked, Guy Hazan, Ehud Banne, Galina Ling, Odeya David, Eilon Shany, Annick Raas-Rothschild, Yair Anikster, Katya Kneller, Eli Hershkovitz, Yuval E. Landau, Ronen Spiegel, Yoav Zehavi, Orna Staretz-Chacham
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Lysosomal storage disorder
COVID-19
Enzyme replacement therapy
Online Access:https://doi.org/10.1186/s13023-021-02007-9

Internet

https://doi.org/10.1186/s13023-021-02007-9

Similar Items